Cost and policy implications from the increasing prevalence of obesity and diabetes mellitus

Ogden Hedley, 2004, Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002, JAMA, 291, 2847, 10.1001/jama.291.23.2847 2004, Prevalence of overweight and obesity among adults with diagnosed diabetes—United States, 1988–1994 and 1999–2002, MMWR Morb Mortal Weekly Rep, 53, 1066 2005 Harris, 1998, Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey, 1988–1994, Diabetes Care, 21, 518, 10.2337/diacare.21.4.518 Unwin, 2002, Impaired glucose tolerance and impaired fasting glycaemia: The current status on definition and intervention, Diabet Med, 19, 708, 10.1046/j.1464-5491.2002.00835.x Benjamin, 2003, Estimated number of adults with prediabetes in the US in 2000: Opportunities for prevention, Diabetes Care, 26, 645, 10.2337/diacare.26.3.645 Gu, 1999, Diabetes and decline in heart disease mortality in US adults, JAMA, 281, 1291, 10.1001/jama.281.14.1291 Wingard, 1995, Heart disease and diabetes, 429 Buse, 2007, Primary prevention of cardiovascular diseases in people with diabetes mellitus: A scientific statement from the American Heart Association and the American Diabetes Association, Circulation, 115, 114, 10.1161/CIRCULATIONAHA.106.179294 Haffner, 1998, Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction, N Engl J Med, 339, 229, 10.1056/NEJM199807233390404 Ford, 1997, Weight change and diabetes incidence: Findings from a national cohort of US adults, Am J Epidemiol, 146, 214, 10.1093/oxfordjournals.aje.a009256 Resnick, 2000, Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults, J Epidemiol Community Health, 54, 596, 10.1136/jech.54.8.596 Colditz, 1995, Weight gain as a risk factor for clinical diabetes mellitus in women, Ann Intern Med, 122, 481, 10.7326/0003-4819-122-7-199504010-00001 Reaven, 2004, Obesity, insulin resistance, and cardiovascular disease, Recent Prog Horm Res, 59, 207, 10.1210/rp.59.1.207 Haffner, 2006, Abdominal obesity, insulin resistance, and cardiovascular risk in pre-diabetes and type 2 diabetes, Eur Heart J Suppl., 8, B20, 10.1093/eurheartj/sul004 2001 Mokdad, 2003, Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001, JAMA, 289, 76, 10.1001/jama.289.1.76 Michaud, 2001, Physical activity, obesity, height, and the risk of pancreatic cancer, JAMA, 286, 921, 10.1001/jama.286.8.921 Giovannucci, 2007, The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas, Gastroenterology, 132, 2208, 10.1053/j.gastro.2007.03.050 Must, 1999, The disease burden associated with overweight and obesity, JAMA, 282, 1523, 10.1001/jama.282.16.1523 Wee, 2000, Screening for cervical and breast cancer: Is obesity an unrecognized barrier to preventive care?, Ann Intern Med, 132, 697, 10.7326/0003-4819-132-9-200005020-00003 Østbye, 2005, Associations between obesity and receipt of screening mammography, Papanicolaou tests, and influenza vaccination: Results from the Health and Retirement Study (HRS) and the Asset and Health Dynamics Among the Oldest Old (AHEAD) Study, Am J Public Health, 95, 1623, 10.2105/AJPH.2004.047803 Alley, 2007, The changing relationship of obesity and disability, 1988–2004, JAMA, 298, 2020, 10.1001/jama.298.17.2020 Libman, 2007 Gregg, 2005, Secular trends in cardiovascular disease risk factors according to body mass index in US adults [published correction appears in JAMA. 2005;294:182], JAMA, 293, 1868, 10.1001/jama.293.15.1868 Fox, 2004, Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: The Framingham Heart Study, Circulation, 110, 522, 10.1161/01.CIR.0000136993.34344.41 Fox, 2007, Increasing cardiovascular disease burden due to diabetes mellitus: The Framingham Heart Study, Circulation, 115, 1544, 10.1161/CIRCULATIONAHA.106.658948 Byers, 1998, The correspondence between coronary heart disease mortality and risk factor prevalence among states in the United States, 1991–1992, Prev Med, 27, 311, 10.1006/pmed.1998.0303 Janssen, 2008, Menopause and the metabolic syndrome: The Study of Women's Health Across the Nation, Arch Intern Med, 168, 1568, 10.1001/archinte.168.14.1568 Kim, 2007, The effect of menopause on the metabolic syndrome among Korean women: The Korean National Health and Nutrition Examination Survey, 2001, Diabetes Care, 30, 701, 10.2337/dc06-1400 Spencer, 1997, Is there a menopausal metabolic syndrome?, Gynecol Endocrinol, 11, 341, 10.3109/09513599709152559 Schneider, 2006, The metabolic syndrome in women, Cardiol Rev, 14, 286, 10.1097/01.crd.0000233757.15181.67 Dong, 2004, Relationship of obesity to depression: A family-based study, Int J Obes Relat Metab Disord, 28, 790, 10.1038/sj.ijo.0802626 Pasic, 2003, Cytokines in depression and heart failure, Psychosom Med, 65, 181, 10.1097/01.PSY.0000058372.50240.38 Katon, 2004, Behavioral and clinical factors associated with depression among individuals with diabetes, Diabetes Care, 27, 914, 10.2337/diacare.27.4.914 Eaton, 2002, Epidemiologic evidence on the comorbidity of depression and diabetes, J Psychosom Res, 53, 903, 10.1016/S0022-3999(02)00302-1 Anderson, 2001, The prevalence of comorbid depression in adults with diabetes: A meta-analysis, Diabetes Care, 24, 1069, 10.2337/diacare.24.6.1069 Eaton, 1996, Depression and risk for onset of type II diabetes. A prospective population-based study, Diabetes Care, 19, 1097, 10.2337/diacare.19.10.1097 Talbot, 2000, A review of the relationship between depression and diabetes in adults: Is there a link?, Diabetes Care, 23, 1556, 10.2337/diacare.23.10.1556 Gonzalez, 2007, Depression, self-care, and medication adherence in type 2 diabetes: Relationships across the full range of symptom severity, Diabetes Care, 30, 2222, 10.2337/dc07-0158 Lin, 2004, Relationship of depression and diabetes self-care, medication adherence, and preventive care, Diabetes Care, 27, 2154, 10.2337/diacare.27.9.2154 Ciechanowski, 2000, Depression and diabetes: Impact of depressive symptoms on adherence, function, and costs, Arch Intern Med, 160, 3278, 10.1001/archinte.160.21.3278 de Groot, 2001, Association of depression and diabetes complications: A meta-analysis, Psychosom Med, 63, 619, 10.1097/00006842-200107000-00015 Egede, 2004, Diabetes, major depression, and functional disability among US adults, Diabetes Care, 27, 421, 10.2337/diacare.27.2.421 Katon, 2004, Cardiac risk factors in patients with diabetes mellitus and major depression, J Gen Intern Med, 19, 1192, 10.1111/j.1525-1497.2004.30405.x Egede, 2002, Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes, Diabetes Care, 25, 464, 10.2337/diacare.25.3.464 2008, Economic costs of diabetes in the US in 2007 [published correction appears in Diabetes Care. 2008;31:1271], Diabetes Care, 31, 596 Ettaro, 2004, Cost-of-illness studies in diabetes mellitus, PharmacoEconomics, 22, 149, 10.2165/00019053-200422030-00002 Hogan, 2003, Economic costs of diabetes in the US in 2002, Diabetes Care, 26, 917, 10.2337/diacare.26.3.917 Zhang, 2004, Application of economic analysis to diabetes and diabetes care, Ann Intern Med, 140, 972, 10.7326/0003-4819-140-11-200406010-00039 Gilmer, 1997, The cost to health plans of poor glycemic control, Diabetes Care, 20, 1847, 10.2337/diacare.20.12.1847 Sturm, 2002, The effects of obesity, smoking, and drinking on medical problems and costs, Health Aff (Millwood), 21, 245, 10.1377/hlthaff.21.2.245 Finkelstein, 2004, State-level estimates of annual medical expenditures attributable to obesity, Obes Res, 12, 18, 10.1038/oby.2004.4 Thorpe, 2004, The impact of obesity on rising medical spending, Health Aff (Millwood) Wolf, 1998, Current estimates of the economic cost of obesity in the United States, Obes Res, 6, 97, 10.1002/j.1550-8528.1998.tb00322.x Barrington Bhattacharya Gilmer, 2005, Predictors of health care costs in adults with diabetes, Diabetes Care, 28, 59, 10.2337/diacare.28.1.59 Zimmet, 2003, Genotype, obesity and cardiovascular disease—has technical and social advancement outstripped evolution?, J Intern Med., 254, 114, 10.1046/j.1365-2796.2003.01170.x Lazar, 2005, How obesity causes diabetes: Not a tall tale, Science, 307, 373, 10.1126/science.1104342 Cawthorne, 2007, Opportunities and challenges for the development of pharmacological therapies for obesity treatment, Obes Rev, 8, 131, 10.1111/j.1467-789X.2007.00332.x Wolf, 1996, Social and economic effects of body weight in the United States, Am J Clin Nutr, 63, 466S, 10.1093/ajcn/63.3.466 Lyznicki, 2001, Obesity: Assesment and management in primary care, Am Fam Physician, 63, 2185 Korner, 2003, The emerging science of body weight regulation and its impact on obesity treatment, J Clin Invest, 111, 565, 10.1172/JCI17953 Young, 2002, The contribution of expanding portion sizes to the US obesity epidemic, Am J Public Health, 92, 246, 10.2105/AJPH.92.2.246 McNaughton, 2008, Dietary patterns, insulin resistance, and incidence of type 2 diabetes in the Whitehall II Study, Diabetes Care, 31, 1343, 10.2337/dc07-1946 Palmer, 2008, Sugarsweetened beverages and incidence of type 2 diabetes mellitus in African American women, Arch Intern Med, 168, 1487, 10.1001/archinte.168.14.1487 Nader, 2008, Moderate-to-vigorous physical activity from ages 9 to 15 years, JAMA, 300, 295, 10.1001/jama.300.3.295 Singh, 2008, High levels of physical inactivity and sedentary behaviors among US immigrant children and adolescents, Arch Pediatr Adolesc Med, 162, 756, 10.1001/archpedi.162.8.756 Mokdad, 2004, Actual causes of death in the United States, 2000 [published correction appears in JAMA. 2005;293:293-294], JAMA, 291, 1238, 10.1001/jama.291.10.1238 1996, Screening for Obesity, 219 Holman, 1998, Assessing the potential for alphaglucosidase inhibitors in prediabetic states, Diabetes Res Clin Pract, 40, S21, 10.1016/S0168-8227(98)00038-2 Herder, 2006, Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: Results from the Finnish Diabetes Prevention Study, Diabetes, 55, 2340, 10.2337/db05-1320 Tuomilehto, 2001, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, N Engl J Med, 344, 1343, 10.1056/NEJM200105033441801 Navarro, 2005, Role of inflammation in diabetic complications, Nephrol Dial Transplant, 20, 2601, 10.1093/ndt/gfi155 2002, Implications of the United Kingdom Prospective Diabetes Study, Diabetes Care, 5, S28 Genuth, 1995, The case for blood glucose control, Adv Intern Med, 40, 573 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 1975, A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of pheniformin therapy, Diabetes, 24, 65 Ohkubo, 1995, Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized, prospective 6-year study, Diabetes Res Clin Pract, 28, 103, 10.1016/0168-8227(95)01064-K 1998, Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [published correction appears in Lancet. 1999;354:602], Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 1998, Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39, BMJ, 317, 713, 10.1136/bmj.317.7160.713 Turner, 1998, Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23), BMJ, 316, 823, 10.1136/bmj.316.7134.823 1998, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) [published correction appears in Lancet. 1998;352:1558], Lancet, 352, 854, 10.1016/S0140-6736(98)07037-8 Emanuele, 1998, Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus, Arch Intern Med, 158, 2485, 10.1001/archinte.158.22.2485 Abraira, 1997, Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial: Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes, Arch Intern Med, 157, 181, 10.1001/archinte.1997.00440230053007 Duckworth, 2001, Glucose control and cardiovascular complications: The VA Diabetes Trial, Diabetes Care, 24, 942, 10.2337/diacare.24.5.942 Meyers, 2006, Baseline achievement of lipid goals and usage of lipid medications in patients with diabetes mellitus (from the Veterans Affairs Diabetes Trial), Am J Cardiol, 98, 63, 10.1016/j.amjcard.2006.01.061 Nissen, 2007, Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes [published correction appears in N Engl J Med. 2007;357:100], N Engl J Med, 356, 2457, 10.1056/NEJMoa072761 Gerstein, 2008, Effects of intensive glucose lowering in type 2 diabetes, N Engl J Med, 358, 2545, 10.1056/NEJMoa0802743 Patel, 2008, Intensive blood glucose control and vascular outcome in patients with type 2 diabetes, N Engl J Med, 358, 2560, 10.1056/NEJMoa0802987 Cefalu, 2008, Glycemic targets and cardiovascular disease, N Engl J Med, 358, 2633, 10.1056/NEJMe0803831 Goran, 2008, Persistence of pre-diabetes in overweight and obese Hispanic children, Diabetes, 57, 3007, 10.2337/db08-0445 Knowler, 2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 346, 393, 10.1056/NEJMoa012512 Chiasson, 2004, Acarbose for the prevention of type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: Facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data, Diabetologia, 47, 969, 10.1007/s00125-004-1409-4 Pan, 1997, Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study, Diabetes Care, 20, 537, 10.2337/diacare.20.4.537 2009, Standards of medical care in diabetes—2008, Diabetes Care, 31, S1 Hoerger, 2007, Cost-effectiveness of screening for pre-diabetes among overweight and obese US adults, Diabetes Care, 30, 2874, 10.2337/dc07-0885 Engelgau, 2002, Identifying the target population for primary prevention: The trade-offs, Diabetes Care, 25, 2098, 10.2337/diacare.25.11.2098 Meigs, 2004, Using metabolic syndrome traits for efficient detection of impaired glucose tolerance, Diabetes Care, 27, 1417, 10.2337/diacare.27.6.1417 Cherry, 2007 Hiss, 1996, Barriers to care in non-insulin-dependent diabetes mellitus. The Michigan experience, Ann Intern Med, 124, 146, 10.7326/0003-4819-124-1_Part_2-199601011-00012 Stewart, 2008, The United States endocrinology workforce: A supply-demand mismatch, J Clin Endocrinol Metab, 93, 1164, 10.1210/jc.2007-1920 Dagogo-Jack, 2002, Preventing diabetes-related morbidity and mortality in the primary care setting, J Natl Med Assoc, 94, 549 Wilding, 2007, Treatment strategies for obesity, Obes Rev, 8, 137, 10.1111/j.1467-789X.2007.00333.x 1998 Janiszewski, 2007, Does waist circumference predict diabetes and cardiovascular disease beyond commonly evaluated cardiometabolic risk factors?, Diabetes Care, 30, 3105, 10.2337/dc07-0945 2003 Christakis, 2007, The spread of obesity in a large social network over 32 years, N Engl J Med, 357, 370, 10.1056/NEJMsa066082 Foster, 1997, Resting energy expenditure in obese African American and Caucasian women, Obes Res, 5, 1, 10.1002/j.1550-8528.1997.tb00276.x Yanovski, 1997, Resting metabolic rate in African-American and Caucasian girls, Obes Res, 5, 321, 10.1002/j.1550-8528.1997.tb00558.x Andersson, 1990, Influence of menopause on dietary treatment of obesity, J Intern Med, 227, 173, 10.1111/j.1365-2796.1990.tb00139.x Saydah, 2004, Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes, JAMA, 291, 335, 10.1001/jama.291.3.335 Garfield, 2003, Considerations for diabetes translational research in real-world settings, Diabetes Care, 26, 2670, 10.2337/diacare.26.9.2670 El-Kebbi, 1999, Diabetes in urban African-Americans. XV. Identification of barriers to provider adherence to management protocols, Diabetes Care, 22, 1617, 10.2337/diacare.22.10.1617 El-Kebbi, 1997, Diabetes in urban African-Americans. IX. Provider adherence to management protocols, Diabetes Care, 20, 698, 10.2337/diacare.20.5.698 Berlowitz, 1998, Inadequate management of blood pressure in a hypertensive population, N Engl J Med, 339, 1957, 10.1056/NEJM199812313392701 Becker, 1998, Nurse-mediated cholesterol management compared with enhanced primary care in siblings of individuals with premature coronary disease, Arch Intern Med, 158, 1533, 10.1001/archinte.158.14.1533 Saaddine, 2006, Improvements in diabetes processes of care and intermediate outcomes: United States, 1988–2002, Ann Intern Med, 144, 465, 10.7326/0003-4819-144-7-200604040-00005 Jencks, 2000, Quality of medical care delivered to Medicare beneficiaries: A profile at state and national levels, JAMA, 284, 1670, 10.1001/jama.284.13.1670 Murff, 2004, The impact of family history of diabetes on glucose testing and counseling behavior in primary care, Diabetes Care, 27, 2247, 10.2337/diacare.27.9.2247 Glasgow, 2001, Report of the Health Care Delivery Work Group: Behavioral research related to the establishment of a chronic disease model for diabetes care, Diabetes Care, 24, 124, 10.2337/diacare.24.1.124 Phillips, 2001, Clinical inertia, Ann Intern Med, 135, 825, 10.7326/0003-4819-135-9-200111060-00012 Miller, 2006, Use of a glucose algorithm to direct diabetes therapy improves A1C outcomes and defines an approach to assess provider behavior, Diabetes Educ, 32, 533, 10.1177/0145721706290834 Shah, 2005, Clinical inertia in response to inadequate glycemic control: Do specialists differ from primary care physicians?, Diabetes Care, 28, 600, 10.2337/diacare.28.3.600 Wright, 2002, Sulfonylurea inadequacy: Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57) [published correction appears in Diabetes Care. 2002;25:1268], Diabetes Care, 25, 330, 10.2337/diacare.25.2.330 Grant, 2007, Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management, Diabetes Care, 30, 807, 10.2337/dc06-2170 Fleming, 2001, The Diabetes Quality Improvement Project: Moving science into health policy to gain an edge on the diabetes epidemic, Diabetes Care, 24, 1815, 10.2337/diacare.24.10.1815 Leichter, 2002, Cost and reimbursement as determinants of the quality of diabetes care: 3. Reimbursement determinants, Clin Diabetes, 20, 43, 10.2337/diaclin.20.1.43 Parchman, 2006, Encounters by patients with type 2 diabetes—complex and demanding: An observational study, Ann Fam Med, 4, 40, 10.1370/afm.422 Parchman, 2007, Competing demands or clinical inertia: The case of elevated glycosylated hemoglobin, Ann Fam Med, 5, 196, 10.1370/afm.679 Katon, 2008, Long-term effects on medical costs of improving depression outcomes in patients with depression and diabetes, Diabetes Care, 31, 1155, 10.2337/dc08-0032 Kim, 2004, Association of health literacy with self-management behavior in patients with diabetes, Diabetes Care, 27, 2980, 10.2337/diacare.27.12.2980 Ciechanowski, 2001, The patient-provider relationship: Attachment theory and adherence to treatment in diabetes, Am J Psychiatry, 158, 29, 10.1176/appi.ajp.158.1.29 Rothman, 2004, Influence of patient literacy on the effectiveness of a primary care-based diabetes disease management program, JAMA, 292, 1711, 10.1001/jama.292.14.1711 Brown, 2004, Health literacy: Universal precautions needed, J Allied Health, 33, 150 Colagiuri, 2006, The answer to diabetes prevention: Science, surgery, service delivery, or social policy?, Am J Public Health, 96, 1562, 10.2105/AJPH.2005.067587 Chang, 2002, Medical modelling of obesity: A transition from action to experience in a 20th century American medical textbook, Sociol Health Illn, 24, 151, 10.1111/1467-9566.00289 Epstein, 1990, Ten-year follow-up of behavioral, family-based treatment for obese children, JAMA, 264, 2519, 10.1001/jama.1990.03450190051027 Brown, 2007, Prevention of obesity: A review of interventions, Obes Rev, 8, 127, 10.1111/j.1467-789X.2007.00331.x Forster, 1988, Preventing weight gain in adults: A pound of prevention, Health Psychol, 7, 515, 10.1037/0278-6133.7.6.515 Funnell, 2008, National standards for diabetes self-management education, Diabetes Care, 31, S97, 10.2337/dc08-S097 Buse, 2007, Primary prevention of cardiovascular diseases in people with diabetes mellitus: A scientific statement from the American Heart Association and the American Diabetes Association, Diabetes Care, 30, 162, 10.2337/dc07-9917 Casalino, 2003, External incentives, information technology, and organized processes to improve health care quality for patients with chronic diseases, JAMA, 289, 434, 10.1001/jama.289.4.434 Bodenheimer, 2002, Patient self-management of chronic disease in primary care, JAMA, 288, 2469, 10.1001/jama.288.19.2469 Renders, 2001, Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings, Cochrane Database Syst Rev, 1, CD001481 Gilmer, 2006, Impact of office systems and improvement strategies on costs of care for adults with diabetes, Diabetes Care, 29, 1242, 10.2337/dc05-1811 Mangione, 2006, The association between quality of care and the intensity of diabetes disease management programs, Ann Intern Med, 145, 107, 10.7326/0003-4819-145-2-200607180-00008 Ziemer, 2006, An intervention to overcome clinical inertia and improve diabetes mellitus control in a primary care setting: Improving Primary Care of African Americans with Diabetes (IPCAAD) 8, Arch Intern Med, 166, 507, 10.1001/archinte.166.5.507 Ménard, 2005, Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: A randomized controlled trial, CMAJ, 173, 1457, 10.1503/cmaj.050054 Brown, 1995, A community-based, culturally sensitive education and group-support intervention for Mexican Americans with NIDDM: A pilot study of efficacy, Diabetes Educ, 21, 203, 10.1177/014572179502100307 Wagner, 2001, Chronic care clinics for diabetes in primary care: A system-wide randomized trial, Diabetes Care, 24, 695, 10.2337/diacare.24.4.695 Rodondi, 2006, Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus, Ann Intern Med, 144, 475, 10.7326/0003-4819-144-7-200604040-00006 Castro, 2007, Babel babble: Physicians' use of unclarified medical jargon with patients, Am J Health Behav, 31, S85, 10.5993/AJHB.31.s1.11 Schillinger, 2004, Functional health literacy and the quality of physicianpatient communication among diabetes patients, Patient Educ Couns, 52, 315, 10.1016/S0738-3991(03)00107-1 Bodenheimer, 2004, What are the facilitators and barriers in physician organizations' use of care management processes?, Jt Comm J Qual Saf, 30, 505, 10.1016/S1549-3741(04)30059-6 Shojania, 2006, Effects of quality improvement strategies for type 2 diabetes on glycemic control: A meta-regression analysis, JAMA, 296, 427, 10.1001/jama.296.4.427 Williamson, 2004, Primary prevention of type 2 diabetes mellitus by lifestyle intervention: Implications for health policy, Ann Intern Med, 140, 951, 10.7326/0003-4819-140-11-200406010-00036 Adams, 2008, Medication adherence and racial differences in A1C control, Diabetes Care, 31, 916, 10.2337/dc07-1924 Nestle, 2000, Halting the obesity epidemic: A public health policy approach, Public Health Rep, 115, 12, 10.1093/phr/115.1.12 Glasgow, 1999, Evaluating the public health impact of health promotion interventions: The RE-AIM framework, Am J Public Health, 89, 1322, 10.2105/AJPH.89.9.1322 Nestle, 2005, Preventing childhood diabetes: The need for public health intervention, Am J Public Health, 95, 1497, 10.2105/AJPH.2005.069120 Mozaffarian, 2006, Trans fatty acids and cardiovascular disease, N Engl J Med, 354, 1601, 10.1056/NEJMra054035 Lueck, 2006, New York City plans limits on restaurants use of trans fats Steinhauer, 2008, California is first state to ban trans fats Maio, 2007, Social psychological factors in tackling obesity, Obes Rev, 8, 123, 10.1111/j.1467-789X.2007.00330.x Woolf, 2008, The meaning of translational research and why it matters, JAMA, 299, 211, 10.1001/jama.2007.26 2008, Physical activity, the community guide